Rankings
▼
Calendar
SAVA Q1 2022 Earnings — Cassava Sciences, Inc. Revenue & Financial Results | Market Cap Arena
SAVA
Cassava Sciences, Inc.
$116M
Q1 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$15M
Operating Income
-$18M
Net Income
-$18M
EPS (Diluted)
$-0.43
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$24M
Free Cash Flow
-$24M
Stock-Based Comp.
$495,000
Balance Sheet
Total Assets
$244M
Total Liabilities
$7M
Stockholders' Equity
$237M
Cash & Equivalents
$210M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$15M
-$3M
-489.4%
Operating Income
-$18M
-$4M
-404.4%
Net Income
-$18M
-$4M
-397.1%
← FY 2022
All Quarters
Q2 2022 →